Back

TXNIP mediates LAT1/SLC7A5 endocytosis to reduce amino acid uptake in cells entering quiescence

Kahlhofer, J.; Marchet, N.; Seifert, B.; Zubak, K.; Hotze, M.; Egger, A.-S.; Manzl, C.; Weyer, Y.; Weys, S.; Offterdinger, M.; Herzog, S.; Reiterer, V.; Kwiatkowski, M.; Wortmann, S. B.; Nemati, S.; Mayr, J. A.; Zschocke, J.; Radlinger, B.; Thedieck, K.; Huber, L. A.; Farhan, H.; de Araujo, M. E.; Kaser, S.; Scholl-Burgi, S.; Karall, D.; Teis, D.

2024-12-04 cell biology
10.1101/2024.10.29.620655 bioRxiv
Show abstract

Entry and exit from cellular quiescence require dynamic adjustments in nutrient acquisition, yet the mechanisms by which quiescent cells downregulate amino acid (AA) transport remain poorly understood. Here, we demonstrate that cells entering quiescence select plasma membrane-resident AA transporters for endocytosis and lysosomal degradation, to match AA uptake with reduced translation. We identify the -arrestin TXNIP as a key regulator of AA uptake during quiescence, since it mediates the endocytosis of the SLC7A5-SLC3A2 (LAT1-4F2hc) transporter complex in response to reduced AKT signaling. Mechanistically, TXNIP interacts with HECT-type ubiquitin ligases to facilitate transporter ubiquitination. Loss of TXNIP disrupts this regulation, resulting in dysregulated AA uptake, sustained mTORC1 signaling, and accelerated quiescence exit. A novel TXNIP loss-of-function mutation in a patient with severe metabolic disease further supports its role in nutrient homeostasis and human health. These findings highlight TXNIPs role in controlling SLC7A5-SLC3A2 mediated AA acquisition with implications for quiescence biology and disease.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.